Skip to main content
2023 IKCS: Europe Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)

SESSION 4: ORAL ABSTRACTS

Oral Abstract: Cross-trial propensity score weighted analysis of nivolumab plus ipilimumab versus nivolumab monotherapy for patients with untreated advanced renal cell carcinoma

Friday, April 21, 2023
14:17 – 14:27 GMT
Location: Lenox 3

    Lead Author(s)

  • Michael B. Atkins, MD (he/him/his)

    Vice Chair of Department of Medical Oncology
    Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
    Georgetown-Lombardi Comprehensive Cancer Center
    WAshington, District of Columbia, United States

    Slides
Full abstract will be available on April 17, 2023.